Valbenazine

Valbenazine
Clinical data
Trade names	Ingrezza
Other names	NBI-98854
AHFS/Drugs.com	Monograph
MedlinePlus	a617023
License data	US DailyMed: Valbenazine;
Routes of; administration	By mouth
ATC code	N07XX13 (WHO) ;
Legal status
Legal status	US: ℞-only;
Pharmacokinetic data
Protein binding	>99%
Metabolism	Activation by hydrolysis, deactivation by CYP3A, CYP2D6
Metabolites	[+]-α-Dihydrotetrabenazine (active metabolite)
Elimination half-life	15–22 hrs
Excretion	60% urine, 30% faeces
Identifiers
	IUPAC name (2R,3R,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl L-valinate;
CAS Number	1025504-45-3;
PubChem CID	24795069;
DrugBank	DB11915;
ChemSpider	28536134;
UNII	54K37P50KH;
KEGG	D10675; as salt: D10999;
ChEMBL	ChEMBL2364639;
CompTox Dashboard (EPA)	DTXSID801026306 ;
ECHA InfoCard	100.236.234
Chemical and physical data
Formula	C24H38N2O4
Molar mass	418.578 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)C[C@@H]1CN2CCc3cc(c(cc3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC;
	InChI InChI=InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1; Key:GEJDGVNQKABXKG-CFKGEZKQSA-N;

Valbenazine, sold under the brand name Ingrezza, is a medication used to treat tardive dyskinesia.^[1] It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor.^[2]